Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype.

Area of Science:

• Immunology
• Glycobiology
• Biotechnology

Background:

• Dendritic cell (DC) response to glycoconjugates is critical for vaccine and therapeutic development.
• Current methods using microarrays may not accurately predict in vivo responses due to differing presentation modalities.
• Understanding how DCs interact with glycans in soluble, phagocytosable, or immobilized forms is crucial.

Purpose of the Study:

• To investigate and compare dendritic cell (DC) functional responses to glycoconjugates presented in various modalities.
• To assess the impact of glycoconjugate display (soluble, phagocytosable, adsorbed) on DC phenotypes.
• To bridge the gap between microarray data and functional cellular responses.

Main Methods:

• Mannose or glucose conjugated to cationized bovine serum albumin were used as model glycoconjugates.
• Glycoconjugates were presented to DCs in soluble, phagocytosable, and adsorbed (non-phagocytosable) forms.
• High-throughput assays and multivariate general linear models (GLM) analyzed DC phenotypic outcomes.

Main Results:

• Statistically significant differences in DC responses were observed across different display modalities.
• Adsorbed glycoconjugates induced the most pro-inflammatory DC responses, while soluble conjugates induced the least.
• Mannose-glycoconjugate interactions were calcium-dependent and inhibited by anti-DC-SIGN antibodies.

Conclusions:

• The presentation modality of glycoconjugates profoundly influences dendritic cell (DC) activation and phenotype.
• Findings suggest that microarray data may not directly translate to therapeutic efficacy without considering presentation context.
• This study provides a framework for understanding glycan-based immunomodulation and designing more effective glycan-based therapeutics.